Adam Havey, EVP, Business Operations at Emergent BioSolutions Inc. (EBS), sold 37,423 shares at $69.00 ($2.5M) on 2020-04-20, disclosed to the SEC on 2020-04-21.
Open-market sale of $2.5M EBS by EVP, Business Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.00 | 20,414 | $1.3M | 53.1% |
| 2 | $69.00 | 17,009 | $1.2M | 46.9% |
| Total | $66.82 avg | 37,423 | $2.5M | 100% |
| Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |
| EBS | SELL | 2018-11-05 | $653K | — | Filing → |